Quoted from Paul Hopper on the Financial ReviewJan 5th...

Quoted from Paul Hopper on the Financial Review
Jan 5th 2021
https://www.copyright link/companies/healthcare-and-fitness/biotech-veteran-paul-hopper-s-car-t-start-up-set-for-asx-debut-20210105-p56rvj

"Very few small biotechs go through to phase three trials and then go on to sell the drug. For small biotechs, the model we'll follow here is if this shows good signals in phase one or early phase two, we'll probably get an offer.


To get an understand of the trial times, click on the link below to his previous company, Viralytics, which sold to big Pharma Merck on 22nd Feb 18, shortly after positive trial results.
Its good news that Leslie has said she's seeing positive results early on in Imugene's Phase 2 trials.

Look for the amazing treatment result photos at:
Pg6 Leg melanoma Before/ Day 85
Pg 17 Head tumor Pre-treatment/ Day 30/ Day 90
Pg 18 Back skin tumor Pre-treatment/ Day 127
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjD746gyIHvAhUEyzgGHbB7DuMQFjABegQIAhAD&url=http%3A%2F%2Fwww.viralytics.com%2Fwp-content%2Fuploads%2F2018%2F04%2FApril-10-OVC-2018-Presentation.pdf&usg=AOvVaw1Tu2XOP7Xm1RHdk-JLa5hU